Now showing items 1-6 of 6

    • High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort 

      Bayigga, Lois; Nabatanzi, Rose; Naluyima Sekiziyivu, Prossy; Mayanja-Kizza, Harriet; Kamya, Moses R.; Kambugu, Andrew; Olobo, Joseph; Kiragga, Agnes; Kirimunda, Sam; Joloba, Moses; Nakanjako, Damalie (BMC Immunology, 2014)
      Background: Up to 40% of HIV-infected individuals receiving Highly Active Antiretroviral Therapy (HAART) have poor CD4+ T-cell recovery. The role of natural killer (NK) cells in immune recovery during HAART is not well ...
    • A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences. 

      Nakanjako, Damalie; Akena, Dickens; Kaye, Dan K.; Tumwine, James; Okello, Elialilia; Kamya, Moses R.; Nakimuli, Annettee; Kambugu, Andrew; McCullough, Hazel; Mayanja-Kizza, Harriet; Sewankambo, Nelson K. (Health Research Policy and Systems, 2017)
      Background: In the last decade, Makerere University College of Health Sciences (MakCHS) has taken strides in research and training to improve healthcare through collaborative training and research programs. However, ...
    • Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large Ambulatory HIV clinics in Uganda 

      Ssinabulya, Isaac; Kayima, James; Longenecker, Chris; Mary Luwedde, Mary; Fred Semitala, Fred; Kambugu, Andrew; Ameda, Faith; Sam Bugeza, Sam; McComsey, Grace; Freers, Juergen; Nakanjako, Damalie (PLOS One, 2014)
      Background: The increased immune activation and inflammation of chronic HIV-infection and the characteristic dyslipidemias associated with HIV infection and antiretroviral therapy (ART) contribute to an increased risk of ...
    • Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis 

      Boulware, David R.; Meya, David B.; Conrad, Muzoora; Rolfes, Melissa A.; Hullsiek, Katherine Huppler; Musubire, Abdu; Taseera M., Kabanda; Nabeta, Henry W.; Schutz, Charlotte; Williams, Darlisha A.; Rajasingham, Radha; Rhein, Joshua; Thienemann, Friedrich; Lo, Melanie W.; Nielsen, Kirsten; Bergemann, Tracy L.; Kambugu, Andrew; Munabe, Yukari C.; Janoff, Edward N.; Bohjanen, Paul R.; Meintjes, Graeme (The New England Journal of Medicine, 2014)
      Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; however, the question of when ART should ...
    • Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis 

      Boulware, David R.; Meya, David B.; Muzoora, Conrad; Rolfes, Melissa A.; Hullsiek, Katherine Huppler; Musubire, Abdu; Taseera, Kabanda; Nabeta, Henry W.; Schutz, Charlotte; Williams, Darlisha A; Rajasingham, Radha; Rhein, Joshua; Thienemann, Friedrich; Lo, Melanie W; Nielsen, Kirsten; Bergemann, Tracy L.; Kambugu, Andrew; Manabe, Yukari C.; Janoff, Edward N.; Bohjanen, Paul R.; Meintjes, Graeme (Massachusetts Medical Society, 2014)
      Background Cryptococcal meningitis accounts for 20 to 25% of acquired immunodeficiency syndrome–related deaths in Africa. Antiretroviral therapy (ART) is essential for survival; however, the question of when ART should ...
    • “You would not be in a hurry to go back home”: Patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda 

      Sebatta, Deborah Ekusai; Siu, Godfrey; Nabeta, Henry W.; Anguzu, Godwin; Walimbwa, Stephen; Lamorde, Mohammed; Bukenya, Badru; Kambugu, Andrew (BMC, 2020)
      Background: Few studies have examined factors associated with willingness of people living with HIV (PLHIV) to participate in HIV treatment clinical trials in Sub-Saharan Africa. We assessed the factors associated with ...